These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Basu M; Rae MN; McNeal MM; Ward RL Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437 [TBL] [Abstract][Full Text] [Related]
5. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Gil MT; de Souza CO; Asensi M; Buesa J Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999 [TBL] [Abstract][Full Text] [Related]
6. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Choi AH; Knowlton DR; McNeal MM; Ward RL Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596 [TBL] [Abstract][Full Text] [Related]
7. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499 [TBL] [Abstract][Full Text] [Related]
8. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection. Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027 [TBL] [Abstract][Full Text] [Related]
9. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697 [TBL] [Abstract][Full Text] [Related]
10. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Siadat-Pajouh M; Cai L Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595 [TBL] [Abstract][Full Text] [Related]
12. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. Feng N; Burns JW; Bracy L; Greenberg HB J Virol; 1994 Dec; 68(12):7766-73. PubMed ID: 7966566 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761 [TBL] [Abstract][Full Text] [Related]
14. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. Choi AH; Basu M; McNeal MM; Clements JD; Ward RL J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847 [TBL] [Abstract][Full Text] [Related]
15. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422 [TBL] [Abstract][Full Text] [Related]